Trial to Evaluate the Safety & Efficacy of the Omnilink Elite™ Peripheral Balloon-Expandable Stent System in Subjects With Atherosclerotic de Novo or Restenotic Lesions in the Native Common Iliac Artery and/or Native External Iliac Artery
Completed · Phase 3
Conditions studied: Peripheral Vascular Disease
In brief
To determine the safety and efficacy of the Omnilink Elite™ Peripheral Balloon-Expandable Stent System in subjects with atherosclerotic de novo or restenotic lesions in the native common iliac artery and/or native external iliac artery.
Key facts
- Study ID
- NCT01396525
- Run by
- Abbott Medical Devices
- People needed
- 153
- Starts
- 2009-03-01
- Expected to finish
- 2014-06-01
- Last updated by the study team
- 2016-02-08
Who can join
Age: 18 and older, up to 89. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Abbott Vascular — Santa Clara, California, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.